Scientific Program



Breast Cancer



Ovarian Cancer



Cervical Cancer



Endometrial Cancer

Live Stream from Berlin – in Tv Quality

Chat Window: Discuss with us! Send us your questions and comments!

Presidential Lectures
Scientific Lectures
State of the Art Sessions
CMC Panel Discussions
Symposia

Part I: Breast Cancer

	Chair: J.-U. Blohmer Co-Chair: M. P. Goetz
08:55 am	Welcome and Introduction J. Sehouli, J.-U. Blohmer
09:00 am	Presidential Lecture I What is the Role of Surgery in the Era of Targeted Therapies? Escalation or De-escalation? J.-U. Blohmer
09:15 am	Symposium with kind support of Daiichi Sankyo ADCs Moving Forward in Women’s Cancer Chair: J. Sehouli ADCs in Breast Cancer: From Metastatic Disease to Currative Setting J.-U. Blohmer ADCs in Gynaecological Cancers: Innovations and Opportunities K. Pietzner Discussion: Will ADCs Replace Chemotherapy in the Future? J. Sehouli
09:45 am	Presidential Lecture II SERDS in Early-stage and Late-stage Breast Cancer M. P. Goetz
10:05 am	State of the Art Looking for Prognostic and Predictive Factors of Early Breast Cancer Patients – State of the Art and Upcoming Developments NN (Charité)
10:25 am	Panel Discussion (Charité–Mayo) What is the Charité Algorithm? What is the Mayo Algorithm? What is the Best Global Approach? J.-U. Blohmer, A. Wahner-Hendrickson, M. P. Goetz, K. Oualla
10:45 am	Case of the year – Never seen before! Presentation and Q&A Immune CCP and ADC V. Kiver Immune CCP and ADC NN (Mayo Clinic)
11:00 am	Break

Part II: Ovarian Cancer

	Chairs: J. Sehouli, A. Wahner-Hendrickson Co-Chair: M. Renz
11:15 am	Presidential Lecture What is the Role of Surgery in the Era of Targeted Therapies? Escalation or De-escalation? R. L. Coleman
11:30 am	Symposium with kind support of Abbvie The Art of Sequencing: Strategic Decision-Making in Post-Platinum Therapy Making the Right Choice: Therapy Selection in the Post-Platinum Setting G. Konecny Personalized Decisions After Platinum: Matching Therapy to Patient Needs J. Sehouli
	Lectures
12:00 pm	What is the Best Therapy for Advanced Ovarian Cancer? (HRD-positive /HRD-negative) A. Wahner-Hendrickson
12:20 pm	What is Now the Best Therapy in the Post-platinum Phase? (Let’s Break the Definition of Platinum Resistance) J. Sehouli
12:40 pm	Panel Discussion (Charité–Mayo) What is the Charité Algorithm? What is the Mayo Algorithm? What is the Best Global Approach? M. Renz, E. I. Braicu, C. Langstraat, A. Wahner-Hendrickson, N. Mostafa, A. González-Martín
01:00 pm	Case of the year – Never seen before! Presentation and Q&A Low-grade Ovarian Cancer J. Bakkum-Gamez MDS and Ovarian Cancer Recurrence – How to Treat S. S. Njonou Noujiep
01:15 pm	Break

Part III: Cervical Cancer

	Chairs: J. Sehouli, A. Wahner-Hendrickson Co-Chair: M. Z. Muallem
01:35 pm	Presidential Lecture What is the Role of Surgery in the Era of Targeted Therapies? Escalation or De-escalation? P. T. Ramirez
01:50 pm	Symposium with kind support of Genmab Advancing r/m Cervical Cancer Care: The ADC Era From CTx to ADCs: A Decade of Progress in r/m Cervical Cancer Treatment Management of New AEs in the ADC Era in r/m Cervical Cancer Discussion K. Pietzner
	Lectures
02:20 pm	What is the Best Therapy in IB3-III (N0/N1)? Surgery vs. Radio-Chemo vs. Radio-Immuno vs. Induction Chemo Plus Radio-Chemo? M. Z. Muallem Biomarker ctHPV DNA in Surveillance and Treatment of Cervical Cancer A. Garda
02:40 pm	What is the Best Treatment in Relapsed Cervical Cancer? M. Block
03:00 pm	Panel Discussion (Charité–Mayo) What is the Charité Algorithm? What is the Mayo Algorithm? What is the Best Global Approach? R. Chekerov, M. Z. Muallem, A. Garda, M. Block, F. Sen
03:20 pm	Case of the year – Never seen before! Presentation and Q&A Treatment of Vulvar Cancer A. Kumar How to Treat an Extrauterine Cervical Cancer M. Beck
03:35 pm	Break

Part IV: Endometrial Cancer

	Chairs: J. Sehouli, A. Wahner-Hendrickson Co-Chair: E. I. Braicu
03:55 pm	Presidential Lecture What is the Role of Surgery in the Era of Molecular Classification and the Era of Targeted Therapies? Escalation or De-escalation? N. Concin
04:10 pm	Symposium with kind support of GSK Update Endometrial Cancer – Finding the Optimal Treatment For Each Patient Chair: J. Sehouli What’s New Regarding Diagnostics and Staging? E. I. Braicu Tailored Treatment – But How? L. Hanker Patients’ Perspective and Quality of Life: What is Time Toxicity? J. Sehouli
	Lectures
05:10 pm	What is the Best Therapy After Checkpoint Therapy? N. Colombo
05:30 pm	Surveillance vs. Treatment and Use of ITCs in Treatment of Endometrial Cancer G. Choong
05:50 pm	Panel Discussion (Charité–Mayo) What is the Charité Algorithm? What is the Mayo Algorithm? What is the Best Global Approach? K. Pietzner, R. Armbrust, G. Choong, G. Glaser, K. Oualla
06:10 pm	Case of the year – Never seen before! Presentation and Q&A Para-aortic Nodal Recurrence With Combined Anterior and Posterior Approach C. Langstraat Neoadjuvant Immunotherapy in Lynch Syndrome E. C. von Bohlen und Halbach

Status: February 2026; may be subject to change.